Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

norlorcainide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Chronic premature ventricular complexes (PVCs) have been effectively suppressed by oral lorcainide as reported in previous short… 
1984
1984
Electrophysiologic effects of intravenous lorcainide and its major metabolite, norlorcainide, were examined in 18 anesthetized… 
Review
1984
Review
1984
SummaryThis article reviews clinical pharmacokinetic data on 8 new antiarrhythmic agents. Some of these drugs have been studied… 
Review
1984
Review
1984
Lorcainide is a type I antiarrhythmic drug of the local anesthetic type. It can be given either intravenously or orally, and its… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table II
1984
1984
Lorcainide is an antiarrhythmic drug with unusual pharmacokinetics and an active metabolite, norlorcainide, which complicate oral… 
1984
1984
  • D. Keefe
  • The American journal of cardiology
  • 1984
  • Corpus ID: 37543710
Lorcainide is a new type 1 antiarrhythmic drug that is well absorbed orally, with bioavailability increasing with both dose and… 
1983
1983
Lorcainide disposition kinetics were studied after intravenous and oral administration to patients with ventricular arrhythmias… 
1983
1983
The electrophysiologic effects of intravenous lorcainide (2.2 mg/kg) in 10 patients were compared with the electrophysiologic… 
  • table I
  • figure 1
  • figure 2
  • table 2
  • table 3
1982
1982
Lorcainide, a new antiarrhythmic drug, was given to 10 patients with frequent (greater than 1/min) premature ventricular…